
Insulet Corporation
16.88 %
62.63 %
Yet to be announced
Company Overview
Insulet Corporation is a medical device company primarily focused on the development, manufacturing, and sale of the Omnipod System, an innovative insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of a disposable tubeless insulin delivery Pod and a handheld Personal Diabetes Manager (PDM) that wirelessly controls the Pod.
The company's flagship product, the Omnipod DASH System, provides a simple, wearable, automated insulin delivery solution that gives users up to three days of non-stop insulin delivery, without the need for multiple daily injections or the complexity of traditional pump therapy.
Revenue Sources
PassBased on the company's financial statements and SEC filings, Insulet Corporation generates its revenue primarily from the sale of its Omnipod insulin delivery systems and related diabetes management products. These medical devices serve a critical healthcare need and are not considered haram products or services.
Reliance on Interest
Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
---|---|---|---|---|---|---|
Dec. 31, 2024 | $597.5m | $496.9m | - | $8.7m | 0.00% | 1.75% |
Sept. 30, 2024 | $543.9m | $468.1m | - | $12.3m | 0.00% | 2.63% |
June 30, 2024 | $488.5m | $444.9m | - | $11.0m | 0.00% | 2.47% |
March 31, 2024 | $441.7m | $395.5m | - | $10.7m | 0.00% | 2.71% |
Examining the last four quarters, the company's interest expense to total expense ratios were consistently below 5%. The ratios calculated from the financial data show that interest expenses are not a material part of the company's business model or operations.
Operational Ethics
PassAfter reviewing available information from SEC filings and company reports, there is no evidence of significant ongoing associations with entities involved in human rights violations. The company's primary operations and manufacturing facilities are located in the United States and Malaysia.
Comments